Status:

RECRUITING

Precision of Pacient-specific Instrumented Open Wedge High Tibial Osteotomy vs Conventional Technicque

Lead Sponsor:

University of Malaga

Collaborating Sponsors:

Hospital Universitario Virgen de la Victoria

Conditions:

Arthritis (Knee)

Varus Knee

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

This study is a randomized clinical trial that will compare two surgical techniques for patients with knee osteoarthritis and varus deformity who are candidates for medial opening wedge high tibial os...

Detailed Description

Medial opening wedge high tibial osteotomy is a well-established surgical procedure to correct knee alignment in patients with medial knee osteoarthritis and varus deformity. The accuracy of the bone ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Informed consent: able to sign informed consent
  • Clinical: predominantly medial pain/limitation refractory ≥3-6 months
  • Mobility: flexion ≥90º and flexion contracture ≤10º Stability: varus/valgus and pivot-shift ≤ grade 1.
  • Radiology:
  • Medial gonarthrosis Ahlbäck I-III with preserved lateral compartment.
  • Patellofemoral Iwano 0-2 without disabling patellofemoral pain.
  • Varus alignment: HKA 4-10°.
  • Predominantly tibial deformity (decreased MPTA; LDFA close to normal) according to planning.
  • Anatomy/technical feasibility: proximal tibial morphology suitable for medial opening osteotomy and PSI guide placement.
  • Exclusion criteria:
  • Comorbidity/clinical situations:
  • Inflammatory arthritis (e.g., RA, spondyloarthropathies), unresolved previous joint infection or osteomyelitis.
  • Severe peripheral vasculopathy (ABI \<0.7), advanced peripheral neuropathy or Charcot foot.
  • Poorly controlled diabetes (HbA1c \>8.5%), advanced renal/hepatic failure (eGFR \<30 ml/min/1.73 m²; Child-Pugh B/C).
  • Smoking \>20 cigarettes/day without commitment to cessation; active IV drug use or uncontrolled alcoholism.
  • BMI \>35 kg/m².
  • Disorder affecting gait (e.g., neurological disease).
  • Inability to walk at a speed of at least 0.8m/s
  • Anatomy/radiology
  • Multiplanar deformities not correctable with isolated medial opening tibial valgus osteotomy (e.g., dominant femoral deformity).
  • Severe medial subchondral bone defect or extensive necrosis.
  • Sequelae of proximal tibia fracture or previous ipsilateral HTO that prevent correction or guide use.
  • Treatments/medication and logistics
  • Anticoagulation/antiplatelet therapy that cannot be suspended or bridged.
  • Systemic corticosteroids \>10 mg/day or high-risk immunosuppressants without possibility of adjustment.
  • Intra-articular infiltration (HA/CS/PRP) within the previous 60 days (respect defined wash-out).
  • Pregnancy.
  • Participation in another interfering trial.
  • Inability to undergo CT (e.g., uncontrollable claustrophobia).
  • Inability to complete ≥12 months of follow-up.

Exclusion

    Key Trial Info

    Start Date :

    November 15 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    October 1 2028

    Estimated Enrollment :

    50 Patients enrolled

    Trial Details

    Trial ID

    NCT07212777

    Start Date

    November 15 2025

    End Date

    October 1 2028

    Last Update

    November 17 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Hospital Universitario Virgen de la Victoria de Málaga

    Málaga, Málaga, Spain, 29010